{"id":"https://openalex.org/W3030338735","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e13092","title":"Feasibility of real-time serial comprehensive tumor analytics: Pilot study of olaparib and durvalumab in metastatic triple negative breast cancer (mTNBC).","display_name":"Feasibility of real-time serial comprehensive tumor analytics: Pilot study of olaparib and durvalumab in metastatic triple negative breast cancer (mTNBC).","publication_year":2020,"publication_date":"2020-05-20","ids":{"openalex":"https://openalex.org/W3030338735","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e13092","mag":"3030338735"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.15_suppl.e13092","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e13092","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.e13092","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064866541","display_name":"Allen Li","orcid":"https://orcid.org/0000-0001-7482-8204","observed_orcids":["https://orcid.org/0000-0001-7482-8204"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allen Li","raw_affiliation_strings":["Oregon Health & Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047361129","display_name":"Marilyne Labrie","orcid":"https://orcid.org/0000-0003-3957-5533","observed_orcids":["https://orcid.org/0000-0003-3957-5533"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marilyne Labrie","raw_affiliation_strings":["Oregon Health and Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health and Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082741754","display_name":"Jacqueline Vuky","orcid":"https://orcid.org/0000-0001-5795-3361","observed_orcids":["https://orcid.org/0000-0001-5795-3361"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacqueline Vuky","raw_affiliation_strings":["Oregon Health & Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114191061","display_name":"Jeong Youn Lim","orcid":"https://orcid.org/0009-0000-5503-998X","observed_orcids":["https://orcid.org/0009-0000-5503-998X"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeong Youn Lim","raw_affiliation_strings":["Dept of Public Health and Preventive Medicine Oregon Health & Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Public Health and Preventive Medicine Oregon Health & Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058976660","display_name":"Brett Johnson","orcid":"https://orcid.org/0000-0001-6810-551X","observed_orcids":["https://orcid.org/0000-0001-6810-551X"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brett Johnson","raw_affiliation_strings":["Oregon Health and Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health and Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053075572","display_name":"Sam Sivagnanam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sam Sivagnanam","raw_affiliation_strings":["OHSU Knight Cancer Institute, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OHSU Knight Cancer Institute, Portland, OR;","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091700539","display_name":"Courtney B. Betts","orcid":"https://orcid.org/0000-0002-0432-0445","observed_orcids":["https://orcid.org/0000-0002-0432-0445"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney Betts","raw_affiliation_strings":["Oregon Health and Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health and Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025353193","display_name":"Lisa M. Coussens","orcid":"https://orcid.org/0000-0003-2389-1865","observed_orcids":["https://orcid.org/0000-0003-2389-1865"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Coussens","raw_affiliation_strings":["Oregon Health and Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health and Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026593581","display_name":"Christopher L. Corless","orcid":"https://orcid.org/0000-0003-4871-8364","observed_orcids":["https://orcid.org/0000-0003-4871-8364"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher L. Corless","raw_affiliation_strings":["OHSU Knight Cancer Institute, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OHSU Knight Cancer Institute, Portland, OR;","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056156623","display_name":"Raymond C. Bergan","orcid":"https://orcid.org/0000-0001-8690-4876","observed_orcids":["https://orcid.org/0000-0001-8690-4876"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raymond C. Bergan","raw_affiliation_strings":["Oregon Health & Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028899187","display_name":"Joe W. Gray","orcid":"https://orcid.org/0000-0001-9225-6756","observed_orcids":["https://orcid.org/0000-0001-9225-6756"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joe W. Gray","raw_affiliation_strings":["Oregon Health & Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005221518","display_name":"Gordon Brent Mills","orcid":"https://orcid.org/0000-0002-0144-9614","observed_orcids":["https://orcid.org/0000-0002-0144-9614"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gordon B. Mills","raw_affiliation_strings":["Oregon Health & Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070623583","display_name":"Zahi Ibrahim Mitri","orcid":"https://orcid.org/0000-0001-8765-7723","observed_orcids":["https://orcid.org/0000-0001-8765-7723"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zahi Ibrahim Mitri","raw_affiliation_strings":["Oregon Health and Science University, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health and Science University, Portland, OR;","institution_ids":["https://openalex.org/I165690674"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"15_suppl","first_page":"e13092","last_page":"e13092"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.5321999788284302,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.5321999788284302,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.3246999979019165,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.09149999916553497,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-triple-negative-breast-cancer","display_name":"metastatic triple-negative breast cancer","score":0.9729999899864197},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9729999899864197},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":1.0},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.6629999876022339},{"id":"https://openalex.org/keywords/adaptive-resistance","display_name":"adaptive resistance","score":0.49900001287460327},{"id":"https://openalex.org/keywords/reverse-phase-protein-array","display_name":"reverse phase protein array","score":0.8169999718666077},{"id":"https://openalex.org/keywords/cyclic-immunofluorescence","display_name":"cyclic immunofluorescence","score":0.9210000038146973},{"id":"https://openalex.org/keywords/multiplex-immunohistochemistry","display_name":"multiplex immunohistochemistry","score":0.9750000238418579},{"id":"https://openalex.org/keywords/immune-infiltration","display_name":"immune cell infiltration","score":0.6840000152587891},{"id":"https://openalex.org/keywords/treatment-response-monitoring","display_name":"treatment response monitoring","score":0.30799999833106995}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8968204259872437},{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.7691388130187988},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6646873950958252},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6303331851959229},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.5837663412094116},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5684242248535156},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.5423662662506104},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47590121626853943},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.47100749611854553},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.46344566345214844},{"id":"https://openalex.org/C2780416959","wikidata":"https://www.wikidata.org/wiki/Q22907415","display_name":"Companion diagnostic","level":3,"score":0.44561389088630676},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42130836844444275},{"id":"https://openalex.org/C2781188995","wikidata":"https://www.wikidata.org/wiki/Q6934982","display_name":"Multiplex","level":2,"score":0.42064306139945984},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3507245182991028},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2594459652900696},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.13658329844474792},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.0},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.0},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.15_suppl.e13092","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e13092","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.e13092","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3206950501","https://openalex.org/W4393983007","https://openalex.org/W4282936253","https://openalex.org/W2947816590","https://openalex.org/W6976884028","https://openalex.org/W7223259613","https://openalex.org/W4402029898","https://openalex.org/W4220824603","https://openalex.org/W7129498471","https://openalex.org/W4411300150"],"abstract_inverted_index":{"e13092":[0],"Background:":[1],"Longitudinal":[2],"analysis":[3,30,87,169,189],"of":[4,16,41,46,54,64,186,201],"serial":[5],"tumor":[6],"biopsies":[7,84,114],"is":[8,44],"an":[9,70,173],"under-utilized":[10],"approach":[11],"to":[12,25,31,78,190,196],"studying":[13],"adaptive":[14],"mechanisms":[15],"resistance.":[17],"We":[18],"have":[19],"established":[20],"a":[21,58,149],"comprehensive":[22],"analytic":[23],"platform":[24],"evaluate":[26],"real-time":[27,188],"trial":[28,213],"sample":[29,158],"inform":[32,191],"precision":[33],"oncology":[34],"combinations":[35],"in":[36,162,175,207],"mTNBC.":[37],"The":[38],"primary":[39,124],"endpoint":[40,125],"the":[42,123,156,184,197],"study":[43],"feasibility":[45,185],"completing":[47],"all":[48,118,129],"CLIA":[49,89],"assays":[50,90,102],"within":[51],"28":[52],"days":[53],"biopsy.":[55],"Methods:":[56],"Following":[57],"pre-treatment":[59],"biopsy":[60,73],"and":[61,74,82,96,107,122,136,172,199],"4":[62],"weeks":[63],"olaparib":[65,204],"monotherapy":[66],"mTNBC":[67,208],"patients":[68,130,138],"underwent":[69,85],"on-treatment":[71],"(tx)":[72],"durvalumab":[75],"was":[76,126,133],"added":[77],"their":[79],"therapy.":[80],"Pre-":[81],"on-tx":[83,157],"comparative":[86],"using":[88],"(immunohistochemistry-IHC,":[91],"whole":[92],"exome":[93],"seq,":[94],"RNAseq":[95],"phospho-proteomics)":[97],"as":[98,100],"well":[99,134],"research":[101],"(multiplex":[103],"IHC-mIHC,":[104],"cyclic":[105],"immunofluorescence-IF,":[106],"reverse":[108],"phase":[109],"protein":[110,163,167],"array-RPPA).":[111],"Results:":[112],"Serial":[113],"were":[115],"obtained":[116],"from":[117],"3":[119],"enrolled":[120],"patients,":[121],"achieved":[127,139],"for":[128],"(Table).":[131],"Treatment":[132],"tolerated,":[135],"2":[137],"clinical":[140],"benefit":[141],">":[142,153],"6":[143],"months.":[144],"In":[145],"one":[146],"patient":[147],"with":[148],"prolonged":[150],"CR":[151],"(":[152],"18":[154],"months),":[155],"exhibited":[159],"dramatic":[160],"changes":[161],"network":[164],"rewiring":[165],"by":[166,178],"data":[168],"(RPPA,":[170],"cyclic-IF),":[171],"increase":[174],"immune":[176],"infiltrate":[177],"mIHC.":[179],"Conclusions:":[180],"This":[181,194],"pilot":[182],"confirmed":[183],"rapid":[187],"treatment":[192],"decisions.":[193],"led":[195],"development":[198],"initiation":[200],"biomarker":[202],"driven":[203],"combination":[205],"trials":[206],"at":[209],"our":[210],"institution.":[211],"Clinical":[212],"information:":[214],"NCT03544125":[215],".":[216],"[Table:":[217],"see":[218],"text]":[219]},"counts_by_year":[{"year":2022,"cited_by_count":4}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2020-06-05T00:00:00"}